Cordis US
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Florida, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
14201 NW 60th Ave, Miami Lakes, Florida,...Phone Number
(800) 327-7714Website
www.cordis.comRevenue
$969.8 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
6
8
1
2
1
2
About Cordis US
Cordis is a global medical-device company that specializes in interventional cardiovascular technologies. With more than 60 years of experience, it develops and manufactures minimally invasive devices such as guidewires, catheters, balloons, stents, and vascular closure systems to treat coronary and peripheral vascular diseases.Explore more
Cordis US Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cordis US your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Cordis US is spiking on competitors!
Click to see if Cordis US had a recent Job posting/layoffs
Cordis US, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Cordis US has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Cordis US has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Cordis US launches new products
Earning: See what the market has to say on Cordis US recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Cordis US
Recommended Actions
Reach out to Masked Content who joined Cordis US as Masked Content
Find 3 more new buyers
Compare Similar Companies to Cordis US
Compare insights from companies similar to Cordis US, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cordis US is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cordis US is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cordis US.
Cordis US Tech Stack
A closer look at the technologies used by Cordis US
See more technologies
Most Recent Scoops
Hiring Plans
Cordis US has more open roles in Medical & Health than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Cordis US has more open roles in Marketing than it has had at any time in the past 6 months. Technologies mentioned include: Affinity. Areas of expertise include: Templates, Market Development, Marketing, Key Opinion Leader Development, and Medical Device Sales.
Hiring Plans
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Hiring Plans
Cordis US has more open roles in Legal than it has had at any time in the past 12 months. Areas of expertise include: Contract Law.
Hiring Plans
Hiring Plans
Hiring Plans
Cordis US News & Media
Cordis Unveiled Breakthrough Results from SELUTION DeNovo and SELUTION4ISR Randomized Trials at TCT 2025, Transforming Coronary Artery Disease (CAD) Treatment Beyond Stenting
SELUTION DeNovo Trial - the largest randomized Drug Eluting Balloon trial - demonstrates a SELUTION SLR™ DEB strategy is non-inferior to a Drug Eluting Stent treatment strategy in de novo lesions. SELUTION4ISR, a randomized controlled trial, proves SELUTION SLR™ DEB is an alternative to...Cordis to Unveil 12-Month Results from Two SELUTION SLR™ DEB Randomized Clinical Trials at TCT 2025 Late-Breaking Clinical Trials Session
12-month data from pivotal randomized studies underscore Cordis' commitment to shaping the future of cardiovascular care. MIAMI LAKES, Fla., Oct. 21, 2025 /PRNewswire/ -- Cordis, a global leader in interventional cardiovascular technologies, will share late-breaking 12-month results from...Cordis Launches 10,000-Patient Global Coronary Registry for SELUTION SLR™ Drug-Eluting Balloon
Initiating one of the largest coronary drug-eluting balloon registries driving evidence-based practice MIAMI LAKES, Fla., May 19, 2025 /PRNewswire/ -- Cordis, a global leader in interventional cardiovascular technologies, today announced the initiation of the SELUTION Global Coronary...Cordis Announces Positive Results from Two Major Studies Demonstrating Durable Efficacy of SELUTION SLR™ Drug-Eluting Balloon in Complex Peripheral Artery Disease Patients
SELUTION SLR™ Drug-Eluting Balloon (DEB) achieves amongst the highest reported patency for any drug-eluting or drug-coated technology at 3 years in the SELUTION SFA Japan Trial, with 81.5% primary patency. SELUTION SLR™ DEB demonstrates real-world effectiveness and consistency across...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cordis US
Sign Up For FreeTo access detailed company insights
Cordis is a global medical-device company that specializes in interventional cardiovascular technologies. With more than 60 years of experience, it develops and manufactures minimally invasive devices such as guidewires, catheters, balloons, stents, and vascular closure systems to treat coronary and peripheral vascular diseases.... Read More
